These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18270860)

  • 1. Analysis of Wegener's granulomatosis responses to rituximab: current evidence and therapeutic prospects.
    Aouba A; Pagnoux C; Bienvenu B; Mahr A; Guillevin L
    Clin Rev Allergy Immunol; 2008 Feb; 34(1):65-73. PubMed ID: 18270860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjunction of rituximab to steroids and immunosuppressants for refractory/relapsing Wegener's granulomatosis: a study on 8 patients.
    Brihaye B; Aouba A; Pagnoux C; Cohen P; Lacassin F; Guillevin L
    Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S23-7. PubMed ID: 17428359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of refractory retrobulbar granuloma with rituximab in a patient with ANCA-negative Wegener's granulomatosis: a case report.
    Ooka S; Maeda A; Ito H; Omata M; Yamada H; Ozaki S
    Mod Rheumatol; 2009; 19(1):80-3. PubMed ID: 18806927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of ANCA-associated vascularitides].
    Guillevin L; Pagnoux C
    Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations.
    Aries PM; Hellmich B; Voswinkel J; Both M; Nölle B; Holl-Ulrich K; Lamprecht P; Gross WL
    Ann Rheum Dis; 2006 Jul; 65(7):853-8. PubMed ID: 16269425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory Wegener's granulomatosis: effect of rituximab on granulomatous bilateral orbital involvement.
    Avshovich N; Boulman N; Slobodin G; Zeina AR; Rosner I; Rozenbaum M
    Isr Med Assoc J; 2009 Sep; 11(9):566-8. PubMed ID: 19960854
    [No Abstract]   [Full Text] [Related]  

  • 7. Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial.
    Keogh KA; Ytterberg SR; Fervenza FC; Carlson KA; Schroeder DR; Specks U
    Am J Respir Crit Care Med; 2006 Jan; 173(2):180-7. PubMed ID: 16224107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Successful treatment of a patient with refractory Wegener's granulomatosis by rituximab].
    Minami R; Miyamura T; Watanabe H; Takahama S; Yamamoto M; Suematsu E
    Nihon Rinsho Meneki Gakkai Kaishi; 2007 Apr; 30(2):133-8. PubMed ID: 17473516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab for refractory Wegener's granulomatosis.
    Antoniu SA
    Expert Opin Investig Drugs; 2006 Sep; 15(9):1115-7. PubMed ID: 16916277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the therapy of Wegener's granulomatosis.
    Hellmich B; Lamprecht P; Gross WL
    Curr Opin Rheumatol; 2006 Jan; 18(1):25-32. PubMed ID: 16344616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S3. Rituximab for ANCA-associated vasculitides: the French experience.
    Charles P; Guillevin L
    Presse Med; 2013 Apr; 42(4 Pt 2):534-6. PubMed ID: 23453207
    [No Abstract]   [Full Text] [Related]  

  • 12. Rituximab as a new therapeutic option in granulomatosis with polyangiitis: a report of two cases.
    Dalkilic E; Alkis N; Kamali S
    Mod Rheumatol; 2012 Jun; 22(3):463-6. PubMed ID: 21847703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nine patients with anti-neutrophil cytoplasmic antibody-positive vasculitis successfully treated with rituximab.
    Eriksson P
    J Intern Med; 2005 Jun; 257(6):540-8. PubMed ID: 15910558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-CD20 therapy of treatment-resistant Wegener's granulomatosis: favourable but temporary response.
    Omdal R; Wildhagen K; Hansen T; Gunnarsson R; Kristoffersen G
    Scand J Rheumatol; 2005; 34(3):229-32. PubMed ID: 16134730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-cell depletion in Wegener's granulomatosis.
    Hinze CH; Colbert RA
    Clin Rev Allergy Immunol; 2008 Jun; 34(3):372-9. PubMed ID: 18172780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapsed Wegener's granulomatosis after rituximab therapy--B cells are present in new pathological lesions despite persistent 'depletion' of peripheral blood.
    Ferraro AJ; Smith SW; Neil D; Savage CO
    Nephrol Dial Transplant; 2008 Sep; 23(9):3030-2. PubMed ID: 18586761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-cell depletion with rituximab for refractory head and neck Wegener's granulomatosis: a cohort study.
    Martinez Del Pero M; Chaudhry A; Jones RB; Sivasothy P; Jani P; Jayne D
    Clin Otolaryngol; 2009 Aug; 34(4):328-35. PubMed ID: 19673980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
    Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D
    Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids.
    Miloslavsky EM; Specks U; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Ding L; Iklé D; Villareal M; Lim N; Brunetta P; Fervenza FC; Monach PA; Stone JH;
    Arthritis Rheumatol; 2015 Jun; 67(6):1629-36. PubMed ID: 25776953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macular oedema following rituximab infusion in two patients with Wegener's granulomatosis.
    Bussone G; Kaswin G; de Menthon M; Delair E; Brézin AP; Guillevin L
    Clin Exp Rheumatol; 2010; 28(1 Suppl 57):90-2. PubMed ID: 20412711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.